Literature DB >> 34339277

Demographic and Behavioral Risk Factors Associated with Reduced Susceptibility of Neisseria gonorrhoeae to First-Line Antimicrobials in South African Men with Gonococcal Urethral Discharge.

Ranmini S Kularatne1,2, Tendesayi Kufa1,3, Lindy Gumede1, Dumisile V Maseko1, David A Lewis4,5,6.   

Abstract

Neisseria gonorrhoeae is the predominant cause of male urethral discharge in South Africa, and escalating prevalence of gonococcal antimicrobial resistance (AMR) is a major health concern both in-country and globally. We analyzed the demographic, behavioral, and clinical characteristics of 685 men presenting with gonococcal urethral discharge to sentinel surveillance clinics over a 3-year period (2017 to 2019) to determine the burden of factors that are known to be associated with N. gonorrhoeae AMR to first-line therapy (defined as group 1 isolates exhibiting resistance or reduced susceptibility to extended-spectrum cephalosporins or azithromycin). Among 685 men with gonococcal urethral discharge, median age was 28 years (interquartile range [IQR], 24 to 32). Only two men (2/632; 0.3%) self-identified as homosexual; however, on further enquiry, another 16 (2%) confirmed that they had sex with men only. Almost 30% practiced oral sex and were at risk for pharyngeal gonococcal infection. In univariate analysis, male circumcision (odds ratio [OR], 0.69; 95% confidence interval [CI], 0.49 to 0.99) and recent sex outside the country (OR, 1.83; 95% CI, 1.21 to 2.76) were significantly associated with having a category 1 N. gonorrhoeae isolate. In a multivariable model, only sex outside South Africa increased the odds of being infected with a decreased susceptible/resistant N. gonorrhoeae isolate (adjusted odds ratio [aOR], 1.64; 95% CI, 1.05 to 2.55). These findings warrant the intensification of N. gonorrhoeae AMR surveillance among recently arrived migrant and overseas traveler populations, as well as the inclusion of extragenital specimens for N. gonorrhoeae AMR surveillance purposes.

Entities:  

Keywords:  Neisseria gonorrhoeae; South Africa; antimicrobial resistance; gonococcal urethritis; male urethritis; risk factors

Mesh:

Substances:

Year:  2021        PMID: 34339277      PMCID: PMC8448136          DOI: 10.1128/AAC.00389-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Neisseria cinerea with High Ceftriaxone MIC Is a Source of Ceftriaxone and Cefixime Resistance-Mediating penA Sequences in Neisseria gonorrhoeae.

Authors:  Gene Igawa; Yuka Yamagishi; Ken-Ichi Lee; Misato Dorin; Ken Shimuta; Hiroyuki Suematsu; Shu-Ichi Nakayama; Hiroshige Mikamo; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.

Authors:  David M Whiley; Amy Jennison; Julie Pearson; Monica M Lahra
Journal:  Lancet Infect Dis       Date:  2018-07       Impact factor: 25.071

3.  Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.

Authors:  Michelle J Cole; Gianfranco Spiteri; Katy Town; Magnus Unemo; Steen Hoffmann; Stephanie A Chisholm; Andrew J Amato-Gauci; Marita van de Laar; Catherine A Ison
Journal:  Sex Transm Dis       Date:  2014-12       Impact factor: 2.830

4.  Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.

Authors:  Helen Fifer; Usha Natarajan; Lucy Jones; Sarah Alexander; Gwenda Hughes; Daniel Golparian; Magnus Unemo
Journal:  N Engl J Med       Date:  2016-06-23       Impact factor: 91.245

5.  Multidrug-resistant Neisseria gonorrhoeae with reduced cefotaxime susceptibility is increasingly common in men who have sex with men, Amsterdam, the Netherlands.

Authors:  H J C de Vries; J J van der Helm; M F Schim van der Loeff; A P van Dam
Journal:  Euro Surveill       Date:  2009-09-17

6.  Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.

Authors:  Brigitte Lefebvre; Irene Martin; Walter Demczuk; Lucie Deshaies; Stéphanie Michaud; Annie-Claude Labbé; Marie-Claude Beaudoin; Jean Longtin
Journal:  Emerg Infect Dis       Date:  2018-02-17       Impact factor: 6.883

7.  Identification of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain FC428, China.

Authors:  Shao-Chun Chen; Yan Han; Liu-Feng Yuan; Xiao-Yu Zhu; Yue-Ping Yin
Journal:  Emerg Infect Dis       Date:  2019-07-17       Impact factor: 6.883

8.  Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain.

Authors:  Monica M Lahra; Irene Martin; Walter Demczuk; Amy V Jennison; Ken-Ichi Lee; Shu-Ichi Nakayama; Brigitte Lefebvre; Jean Longtin; Alison Ward; Michael R Mulvey; Teodora Wi; Makoto Ohnishi; David Whiley
Journal:  Emerg Infect Dis       Date:  2018-04       Impact factor: 6.883

9.  Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018.

Authors:  David W Eyre; Nicholas D Sanderson; Emily Lord; Natasha Regisford-Reimmer; Kevin Chau; Leanne Barker; Markus Morgan; Robert Newnham; Daniel Golparian; Magnus Unemo; Derrick W Crook; Tim Ea Peto; Gwenda Hughes; Michelle J Cole; Helen Fifer; Anne Edwards; Monique I Andersson
Journal:  Euro Surveill       Date:  2018-07

10.  Two cases of multidrug-resistant Neisseria gonorrhoeae related to travel in south-eastern Asia, France, June 2019.

Authors:  Thibaut Poncin; Manel Merimeche; Aymeric Braille; Mary Mainardis; Cécile Bebear; Hervé Jacquier; Béatrice Berçot
Journal:  Euro Surveill       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.